These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 22748809)

  • 1. Clinical aspects of phage therapy.
    Międzybrodzki R; Borysowski J; Weber-Dąbrowska B; Fortuna W; Letkiewicz S; Szufnarowski K; Pawełczyk Z; Rogóż P; Kłak M; Wojtasik E; Górski A
    Adv Virus Res; 2012; 83():73-121. PubMed ID: 22748809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.
    Chanishvili N
    Adv Virus Res; 2012; 83():3-40. PubMed ID: 22748807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phages. Preface.
    Łobocka M; Szybalski WT
    Adv Virus Res; 2012; 83():xvii-xviii. PubMed ID: 22748816
    [No Abstract]   [Full Text] [Related]  

  • 4. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage as a modulator of immune responses: practical implications for phage therapy.
    Górski A; Międzybrodzki R; Borysowski J; Dąbrowska K; Wierzbicki P; Ohams M; Korczak-Kowalska G; Olszowska-Zaremba N; Łusiak-Szelachowska M; Kłak M; Jończyk E; Kaniuga E; Gołaś A; Purchla S; Weber-Dąbrowska B; Letkiewicz S; Fortuna W; Szufnarowski K; Pawełczyk Z; Rogóż P; Kłosowska D
    Adv Virus Res; 2012; 83():41-71. PubMed ID: 22748808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is needed for phage therapy to become a reality in Western medicine?
    Brüssow H
    Virology; 2012 Dec; 434(2):138-42. PubMed ID: 23059181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial bioagents based on principles of bacteriophage biology: an overview.
    Knoll BM; Mylonakis E
    Clin Infect Dis; 2014 Feb; 58(4):528-34. PubMed ID: 24270166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The next generation of bacteriophage therapy.
    Lu TK; Koeris MS
    Curr Opin Microbiol; 2011 Oct; 14(5):524-31. PubMed ID: 21868281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perspectives of the application of phage therapy in chronic bacterial prostatitis.
    Letkiewicz S; Międzybrodzki R; Kłak M; Jończyk E; Weber-Dąbrowska B; Górski A
    FEMS Immunol Med Microbiol; 2010 Nov; 60(2):99-112. PubMed ID: 20698884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
    Burrowes B; Harper DR; Anderson J; McConville M; Enright MC
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage cocktails and the future of phage therapy.
    Chan BK; Abedon ST; Loc-Carrillo C
    Future Microbiol; 2013 Jun; 8(6):769-83. PubMed ID: 23701332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M; Adamia R
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is phage therapy acceptable in the immunocompromised host?
    Borysowski J; Górski A
    Int J Infect Dis; 2008 Sep; 12(5):466-71. PubMed ID: 18400541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteriophages as antibacterial agents].
    Shasha SM; Sharon N; Inbar M
    Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New perspectives of the phage therapy].
    Eyer L; Pantůcek R; Růzicková V; Doskar J
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI
    Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage therapy: past history and future prospects.
    Carlton RM
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z; Bagasra O; Pace DG
    J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
    Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
    J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
    Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
    Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.